Wikidata

(Q63397801)

English

Phase 2b Study to Evaluate the Efficacy and Safety of GBR 830 in Adults With Moderate to Severe Atopic Dermatitis

clinical trial

In more languages

Statements

title
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of GBR 830 in Adult Subjects With Moderate to Severe Atopic Dermatitis. (English)
0 references
medical condition
dermatitis
0 references
eczema
0 references
country
Canada
0 references
Germany
0 references
Poland
0 references
start time
31 May 2018
0 references
end time
April 2020
0 references
number of participants
392
0 references
minimum age
18 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q63397801&oldid=2131442526"